ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0852

3-dimensional Shape Changes of the Knee over 4 Years Are Linear and Progressive but Much More Rapid in Osteoarthritic Joints: Data from the Osteoarthritis Initiative

Alan Brett1, Philip G Conaghan2 and Michael Bowes3, 1Imorphics, Austin, TX, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 3Imorphics, Manchester, United Kingdom

Meeting: ACR Convergence 2024

Keywords: Biomarkers, Magnetic resonance imaging (MRI), Osteoarthritis, Pathology Bone Joint, Structure

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: Imaging of Rheumatic Diseases

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: The specific bony changes of osteophyte growth and “bone attrition” (broadening and flattening of the femoral condyles) associated with OA have been recognized in radiographs for many years. Recently, the development of automated measurement of a z-score of true 3D knee femoral bone shape (“B-score”) from MR or CT images has demonstrated that bone shape may provide a continuous indication of OA status, may predict future OA onset, and is associated with patient-important endpoints such as pain, loss of function and joint replacement [1]. Here we explore longitudinal changes of this bone shape measure.

Methods: B-scores were automatically derived from Osteoarthritis Initiative DESS MR images of all knees that had images of the right knee acquired at baseline, 1, 2, 3 and 4-year timepoints, using the same imaging coil. Total number of days from baseline for each acquisition was used to calculate time intervals. B-score slopes were modelled by linear least-squares (LLM) regression over 4 years. The average slopes were compared for Kellgren-Lawrence Grade (KLG) baseline status. We tested negative slopes against a null hypothesis of a zero slope at a significance level of p< 0.05. Linearity of slopes was tested by comparison of fitted B-score values from the LLM with the residual at each timepoint. Akaike and Bayesian Information Criterion tests both indicated an optimal 3-components for a Gaussian Mixture Model of the B-score slope distribution

Results: The analysis set comprised 2371 knees (44% male) with baseline KLG of 0: 941, 1: 465, 2: 606, 3: 303, 4: 54. Average slopes and intercepts from LLM for each KLG are shown in Fig. 1. The number of negative slopes significantly different (p< 0.05) from zero was 13 (3.7% of all 352 negative slopes). Fig. 2 shows that distribution of the LLS fitted B-score values compared to residuals for all subjects and timepoints was centered on zero, with no off-axis trend, indicating that B-score slopes are homoscedastic and linear. The three-component GMM of the distribution of B-score annual slopes is shown in Fig. 3 with the mean (µ), standard deviation (σ) and probability of an individual knee being in the component (π) reported for each Gaussian component.

Conclusion: We found no evidence of negative bone shape slopes which might indicate bone shape reverting to a less pathological state. Instead, bone shape changes associated with OA were unidirectional and linear, at least over 4 years, supporting the use of this measurement in clinical trials. The KL grades associated with normal or doubtful radiographic OA (0/1) appear to have very small annual B-score slopes of ~0.04 per annum, whereas KLG2-4 all have slopes ~3-4x larger indicating a larger proportion of faster bone shape progressors at the higher KL grades. The GMM result suggests three B-score trajectories: a normal “aging” mean annual rate of 0.04 (comprising 71% of our sample set) and an OA “progression” mean rate of 0.19 (21% of the set). A third mean rate of 0.38 (8% of the set) may indicate a more rapid progressor subgroup or variability related to measurement at higher rates of progression.

[1] Bowes et al. (2021) ARD 80(4) 502-508.

Supporting image 1

Figure 1: Average 4-year B-score LLM slopes for differing KLG. Error bars are SE.

Supporting image 2

Figure 2: Fitted B-score values vs residuals of LLM B-score slopes for all subject timepoints over 4 years.

Supporting image 3

Figure 3: Histogram and three-component GMM of distribution of B-score 4-year slopes. Legend indicates mean (µ), standard deviation (σ) and probability of an individual being in the Gaussian component (π).


Disclosures: A. Brett: Stryker, 3, 11; P. Conaghan: AbbVie, 2, 6, Eupraxia Pharmaceuticals, 2, Galapagos, 2, Genascence, 2, Grünenthal, 2, GSK, 2, Janssen, 2, Levicept, 2, Lilly, 2, 6, Medipost, 2, Merck, 2, Moebius, 2, Novartis, 2, 6, Orion, 2, Pacira, 2, Sandoz, 6, Stryker, 2, Takeda, 2, TrialSpark, 2; M. Bowes: Stryker, 3, 11.

To cite this abstract in AMA style:

Brett A, Conaghan P, Bowes M. 3-dimensional Shape Changes of the Knee over 4 Years Are Linear and Progressive but Much More Rapid in Osteoarthritic Joints: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/3-dimensional-shape-changes-of-the-knee-over-4-years-are-linear-and-progressive-but-much-more-rapid-in-osteoarthritic-joints-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/3-dimensional-shape-changes-of-the-knee-over-4-years-are-linear-and-progressive-but-much-more-rapid-in-osteoarthritic-joints-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology